623 related articles for article (PubMed ID: 16034750)
1. Predictability model of the need for extracorporeal membrane oxygenation in neonates with meconium aspiration syndrome treated with inhaled nitric oxide.
Friedlich P; Noori S; Stein J; Shin C; Burns C; Ramanathan R; Seri I
J Pediatr Surg; 2005 Jul; 40(7):1090-3. PubMed ID: 16034750
[TBL] [Abstract][Full Text] [Related]
2. Risk of need for extracorporeal membrane oxygenation support in neonates with congenital diaphragmatic hernia treated with inhaled nitric oxide.
Sebald M; Friedlich P; Burns C; Stein J; Noori S; Ramanathan R; Seri I
J Perinatol; 2004 Mar; 24(3):143-6. PubMed ID: 14961042
[TBL] [Abstract][Full Text] [Related]
3. Hypoxic respiratory failure in term newborns: clinical indicators for inhaled nitric oxide and extracorporeal membrane oxygenation therapy.
Fakioglu H; Totapally BR; Torbati D; Raszynski A; Sussmane JB; Wolfsdorf J
J Crit Care; 2005 Sep; 20(3):288-93. PubMed ID: 16253800
[TBL] [Abstract][Full Text] [Related]
4. Extracorporeal membrane oxygenation in infants with meconium aspiration syndrome: a decade of experience with venovenous ECMO.
Kugelman A; Gangitano E; Taschuk R; Garza R; Riskin A; McEvoy C; Durand M
J Pediatr Surg; 2005 Jul; 40(7):1082-9. PubMed ID: 16034749
[TBL] [Abstract][Full Text] [Related]
5. Predictors of failure of high-frequency oscillatory ventilation in term infants with severe respiratory failure.
Paranka MS; Clark RH; Yoder BA; Null DM
Pediatrics; 1995 Mar; 95(3):400-4. PubMed ID: 7862480
[TBL] [Abstract][Full Text] [Related]
6. Airway function in infants treated with inhaled nitric oxide for persistent pulmonary hypertension.
Hoskote AU; Castle RA; Hoo AF; Lum S; Ranganathan SC; Mok QQ; Stocks J
Pediatr Pulmonol; 2008 Mar; 43(3):224-35. PubMed ID: 18203182
[TBL] [Abstract][Full Text] [Related]
7. [The role of extracorporeal membrane oxygenation (ECMO) in current neonatology].
Kachel W; Lasch P; Varnholt V; Wirth H; Quintel M
Z Geburtshilfe Neonatol; 1997; 201 Suppl 1():68-76. PubMed ID: 9410532
[TBL] [Abstract][Full Text] [Related]
8. The effect of inhaled nitric oxide on the course of extracorporeal membrane oxygenation and the occurrence of hemorrhagic complications.
de Mol AC; van Heijst AF; de Haan TF; van der Staak FH; Liem KD
ASAIO J; 2009; 55(3):213-6. PubMed ID: 19293708
[TBL] [Abstract][Full Text] [Related]
9. Impact of new treatments for neonatal pulmonary hypertension on extracorporeal membrane oxygenation use and outcome.
Kennaugh JM; Kinsella JP; Abman SH; Hernandez JA; Moreland SG; Rosenberg AA
J Perinatol; 1997; 17(5):366-9. PubMed ID: 9373841
[TBL] [Abstract][Full Text] [Related]
10. Abnormalities of coagulation related to the use of inhaled nitric oxide before extracorporeal membrane oxygenation.
de Mol AC; van Heijst AF; Brouwers M; de Haan TF; van der Staak FH; Liem KD
Pediatr Crit Care Med; 2007 May; 8(3):261-3. PubMed ID: 17417131
[TBL] [Abstract][Full Text] [Related]
11. Developing a systems approach to prevent meconium aspiration syndrome: lessons learned from multinational studies.
Bhutani VK
J Perinatol; 2008 Dec; 28 Suppl 3():S30-5. PubMed ID: 19057608
[TBL] [Abstract][Full Text] [Related]
12. Inhaled nitric oxide and gentle ventilation in the treatment of pulmonary hypertension of the newborn--a single-center, 5-year experience.
Gupta A; Rastogi S; Sahni R; Bhutada A; Bateman D; Rastogi D; Smerling A; Wung JT
J Perinatol; 2002 Sep; 22(6):435-41. PubMed ID: 12168118
[TBL] [Abstract][Full Text] [Related]
13. Experience with mobile inhaled nitric oxide during transport of neonates and children with respiratory insufficiency to an extracorporeal membrane oxygenation center.
Westrope C; Roberts N; Nichani S; Hunt C; Peek GJ; Firmin R
Pediatr Crit Care Med; 2004 Nov; 5(6):542-6. PubMed ID: 15530190
[TBL] [Abstract][Full Text] [Related]
14. [Persistent pulmonary hypertension in premature and newborn infants: selective pulmonary vasodilation with inhaled nitric oxide (iNO)].
Herkenhoff M; Schaible T; Reiss I; Kandzora J; Möller J; Gortner L
Z Geburtshilfe Neonatol; 1998; 202(1):25-9. PubMed ID: 9577919
[TBL] [Abstract][Full Text] [Related]
15. Cardiopulmonary outcome of neonatal extracorporeal membrane oxygenation at ages 10-15 years.
Boykin AR; Quivers ES; Wagenhoffer KL; Sable CA; Chaney HR; Glass P; Bahrami KR; Short BL
Crit Care Med; 2003 Sep; 31(9):2380-4. PubMed ID: 14501970
[TBL] [Abstract][Full Text] [Related]
16. Use of inhaled nitric oxide in the new born period: results from the European Inhaled Nitric Oxide Registry.
Dewhurst C; Ibrahim H; Göthberg S; Jónsson B; Subhedar N;
Acta Paediatr; 2010 Jun; 99(6):854-60. PubMed ID: 20219040
[TBL] [Abstract][Full Text] [Related]
17. Methemoglobin to cumulative nitric oxide ratio and response to inhaled nitric oxide in PPHN.
Pabalan MJ; Nayak SP; Ryan RM; Kumar VH; Lakshminrusimha S
J Perinatol; 2009 Oct; 29(10):698-701. PubMed ID: 19554014
[TBL] [Abstract][Full Text] [Related]
18. Four patterns of response to inhaled nitric oxide for persistent pulmonary hypertension of the newborn.
Goldman AP; Tasker RC; Haworth SG; Sigston PE; Macrae DJ
Pediatrics; 1996 Oct; 98(4 Pt 1):706-13. PubMed ID: 8885950
[TBL] [Abstract][Full Text] [Related]
19. Neonatal nitric oxide use: predictors of response and financial implications.
Truog WE; Castor CA; Sheffield MJ
J Perinatol; 2003 Mar; 23(2):128-32. PubMed ID: 12673262
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis-related criteria in the consideration of extracorporeal membrane oxygenation in neonates previously treated with high-frequency jet ventilation.
Baumgart S; Hirschl RB; Butler SZ; Coburn CE; Spitzer AR
Pediatrics; 1992 Mar; 89(3):491-4. PubMed ID: 1741226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
